2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
62
OTHER
30
NIH
1
NETWORK
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
53
Colorectal Neoplasms
42
Neoplasms
37
Lung Neoplasms
22
Breast Neoplasms
15
Colonic Neoplasms
14
Colonic Polyps
13
Rare Diseases
9
Carcinoma, Non-Small-Cell Lung
9
Carcinoma, Hepatocellular
9
Ovarian Neoplasms
7
Adenoma
7
Pulmonary Disease, Chronic Obstructive
6
Neoplasm Metastasis
6
Heart Failure
6
Head and Neck Neoplasms
6
Rectal Neoplasms
5
Motor Activity
5
Liver Neoplasms
5
Fibrosis
5
Carcinoma, Squamous Cell
5
Barrett Esophagus
5
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Neoplasms by Site
4
Mental Disorders
4
Lymphoma
4
Lung Diseases
4
Leukemia
4
Esophageal Neoplasms
4
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
FED
×
Hereditary Sensory and Autonomic Neuropathies
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled